An overview of the pharmacokinetics and pharmacodynamics of amlodipine in elderly persons with systemic hypertension

Am J Cardiol. 1994 Jan 27;73(3):10A-17A. doi: 10.1016/0002-9149(94)90269-0.

Abstract

Pharmacokinetic and pharmacodynamic data were compared between elderly and young patients with hypertension who received single intravenous doses of amlodipine, a dihydropyridine calcium antagonist, followed by oral administration of amlodipine up to 10 mg once daily for 12 weeks. After intravenous administration, elderly patients had prolonged elimination half-life values (58 +/- 11 vs 42 +/- 8 hr; p < 0.05) caused by decreased clearance (19 +/- 5 vs 7 liters/hr; p < 0.05). Systolic and diastolic blood pressures were significantly decreased from baseline throughout the 3-month treatment period in both groups. After long-term oral administration, elderly and young patients had comparable decreases in mean blood pressure at a given drug plasma concentration. The antihypertensive effect of amlodipine is well correlated with plasma concentration and, at a given concentration, is similar in both elderly and young patients.

MeSH terms

  • Administration, Oral
  • Adult
  • Aged
  • Amlodipine / administration & dosage
  • Amlodipine / pharmacokinetics*
  • Amlodipine / pharmacology*
  • Atrial Natriuretic Factor / blood
  • Biological Availability
  • Blood Pressure / drug effects
  • Blood Pressure Monitors
  • Drug Administration Schedule
  • Half-Life
  • Humans
  • Hypertension / blood
  • Hypertension / drug therapy*
  • Hypertension / physiopathology
  • Male
  • Middle Aged
  • Renin / blood

Substances

  • Amlodipine
  • Atrial Natriuretic Factor
  • Renin